Application 018050
- Type
- NDA
- Sponsor
- UCB INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CORSYM | CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX | SUSPENSION, EXTENDED RELEASE;ORAL | EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.